Loading...
44 companies we cover, 41 of them graded
Every company here put through the same five checks on growth and cash generation. It describes the industry as it reports today — not which of these to buy.
| TMO | THERMO FISHER SCIENTIFIC INC. | A+ | $249.6B | $675.00 | 36.31 | $46.3B | 15.0% |
| DHR | DANAHER CORPORATION | C+ | $157.8B | $224.49 | 39.87 | $25.1B | 15.9% |
| NTRA | NATERA, INC. | B- | $59.5B | $412.56 | — | $2.7B | -7.1% |
| A | AGILENT TECHNOLOGIES, INC. | B+ | $48.7B | $172.79 | 34.08 | $7.4B | 19.5% |
| IQV | IQVIA HOLDINGS INC. | A | $45.1B | $270.37 | 33.54 | $16.6B | 8.3% |
| WAT | Waters Corporation | B | $42.6B | $433.54 | 108.11 | $4.6B | 3.6% |
| IDXX | IDEXX LABORATORIES INC /DE | A+ | $40.9B | $519.26 | 36.49 | $4.6B | 25.0% |
| ILMN | ILLUMINA, INC. | B+ | $40.8B | $270.00 | 50.37 | $4.5B | 18.4% |
| MTD | Mettler-Toledo International Inc. | A+ | $30.3B | $1,511.64 | 34.06 | $4.1B | 21.9% |
| DGX | Quest Diagnostics Inc | B | $26.1B | $236.32 | 25.09 | $11.6B | 9.2% |
| LH | LABCORP HOLDINGS INC. | B | $25.1B | $309.64 | 25.61 | $14.3B | 7.0% |
| GH | GUARDANT HEALTH, INC. | C | $23.8B | $177.25 | — | $1.2B | -38.3% |
| MEDP | Medpace Holdings, Inc. | A+ | $17.3B | $618.88 | 36.34 | $2.8B | 17.7% |
| RVTY | REVVITY, INC | A | $16.9B | $151.11 | 72.30 | $2.9B | 8.2% |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | D | $14B | $292.84 | — | $4B | -6.0% |
| ICLR | ICON plc | A | $13.2B | $172.33 | 331.40 | $8.3B | 0.5% |
| QGEN | QIAGEN N.V. | D+ | $9.6B | $44.18 | 22.77 | $2.1B | 20.3% |
| BLLN | BillionToOne, Inc. | A | $6.6B | $123.08 | 175.83 | $397.4M | 9.5% |
| GRAL | GRAIL, Inc. | B- | $5.7B | $126.89 | — | $165.3M | -236.9% |
| RDNT | RadNet, Inc. | B- | $5.6B | $70.79 | — | $2.3B | -0.9% |
| SHC | SOTERA HEALTH COMPANY | B+ | $5.2B | $18.34 | 32.18 | $1.2B | 13.4% |
| ADPT | ADAPTIVE BIOTECHNOLOGIES CORPORATION | B- | $4.7B | $29.43 | — | $308.1M | -20.7% |
| VCYT | VERACYTE, INC. | A+ | $3.7B | $45.43 | 32.45 | $561.9M | 20.4% |
| CDNA | CAREDX, INC. | B+ | $3.3B | $63.68 | 30.76 | $458.1M | 24.2% |
| WGS | GeneDx Holdings Corp. | C- | $2.6B | $88.40 | — | $454.4M | -23.4% |
| NEO | NeoGenomics, Inc. | B- | $2.5B | $19.33 | — | $766.3M | -6.8% |
| PSNL | Personalis, Inc. | D- | $1.8B | $16.46 | — | $69.7M | -153.8% |
| OPK | OPKO Health, Inc. | F- | $1.2B | $1.64 | — | $587.9M | -12.4% |
| CSTL | CASTLE BIOSCIENCES, INC. | C- | $1.1B | $35.81 | — | $357.3M | -5.4% |
| FLGT | FULGENT GENETICS, INC. | C- | $610.8M | $22.20 | — | $323.9M | -26.0% |
| MYGN | MYRIAD GENETICS, INC. | D- | $398.9M | $4.17 | — | $806.6M | -14.0% |
| BDSX | BIODESIX, INC. | B | $307M | $29.10 | — | $102.9M | -27.0% |
| XGN | EXAGEN INC. | B- | $211.2M | $8.72 | — | $71.1M | -26.6% |
| FRNM | Freenome, Inc. | not rated | $142.5M | $15.99 | — | — | — |
| IMDX | Insight Molecular Diagnostics Inc. | D | $128.3M | $3.92 | — | $1.7M | -2,955.6% |
| BIAF | bioAffinity Technologies, Inc. | F- | $64.2M | $7.93 | — | $5.9M | -257.3% |
| PRPO | PRECIPIO, INC. | A- | $42.3M | $23.65 | — | $27.7M | -4.4% |
| QUCY | Quantum Cyber N.V. | C- | $20.3M | $1.37 | — | $537.1K | -2,992.5% |
| NDRA | ENDRA LIFE SCIENCES INC. | not rated | $9.1M | $6.04 | — | — | — |
| ADVB | Advanced Biomed Inc | not rated | $8.8M | $6.38 | — | — | — |
| XWEL | XWELL, Inc. | F | $7.7M | $0.89 | — | $28.3M | -82.9% |
| MDXH | MDXHEALTH SA | B | $2.9M | $0.57 | — | $107.9M | -31.1% |
| ISPC | iSpecimen Inc. | D- | $1.1M | $1.26 | — | $466.3K | -2,449.0% |
| BNR | Burning Rock Biotech Limited | C- | — | $18.60 | — | $80.4M | -10.3% |
Fundamentals from SEC filings, prices from the last market-data pass. Sort by any column; companies with no figure sort last either way.
Sorted by market cap, largest first; click any column to re-sort. Companies with no figure sort last either way, because a missing P/E means unprofitable rather than cheap. Nothing here is a recommendation.